Dima S, Medeşan C, Moţa G, Moraru I, Sjöquist J, Gheţie V
Eur J Immunol. 1983 Aug;13(8):605-14. doi: 10.1002/eji.1830130802.
Radiolabeled protein A from Staphylococcus aureus (SpA) injected i.v. into mice and rabbits forms a soluble [(IgG)2-(SpA)1]2 complex (Mr = 684 000) which is identical in composition to that formed by SpA in vitro with an equivalent amount or an excess of IgG. A soluble rabbit IgG-SpA complex injected into a mice or rabbits dissociates completely in vivo and a new complex is formed with the IgG of the recipient animal. The half-life of SpA administered to a mouse or a rabbit is therefore the half-life of the IgG-SpA complex formed in vivo. In mice and rabbits the half-life of the complexes formed is 9 and 30 h, respectively, whereas the half-life of rabbit IgG in these animals is 106 and 153 h, respectively. Fragment B of SpA (fSpA) reacts with IgG of mouse and rabbit and forms an (IgG)1-(fSpA)1 complex. Complexes of identical composition are formed if fSpA is injected i.v. into mice and rabbits. The half-life of the complexes in mice and rabbits are much shorter than those of the corresponding free IgG in these animals (up to 15 times). This result suggests that the binding of fSpA to the CH2 and the CH3 domains of IgG alters the function of the site, which controls the catabolism of IgG and is located in the CH2 domain. By contrast, fSpA does not change the Fc receptor-binding site of IgG, indicating that the Fc receptor site and the catabolic site are unrelated to each other.
将放射性标记的金黄色葡萄球菌蛋白A(SpA)静脉注射到小鼠和兔子体内后,会形成一种可溶性的[(IgG)2 - (SpA)1]2复合物(分子量 = 684000),其组成与SpA在体外与等量或过量IgG形成的复合物相同。将可溶性的兔IgG - SpA复合物注射到小鼠或兔子体内后,它会在体内完全解离,并与受体动物的IgG形成新的复合物。因此,给小鼠或兔子注射SpA后的半衰期就是体内形成的IgG - SpA复合物的半衰期。在小鼠和兔子中,形成的复合物的半衰期分别为9小时和30小时,而这些动物体内兔IgG的半衰期分别为106小时和153小时。SpA的B片段(fSpA)与小鼠和兔子的IgG反应并形成(IgG)1 - (fSpA)1复合物。如果将fSpA静脉注射到小鼠和兔子体内,会形成组成相同的复合物。这些复合物在小鼠和兔子体内的半衰期比这些动物体内相应游离IgG的半衰期短得多(高达15倍)。这一结果表明,fSpA与IgG的CH2和CH3结构域结合会改变该位点的功能,该位点控制着IgG的分解代谢,位于CH2结构域。相比之下,fSpA不会改变IgG的Fc受体结合位点,这表明Fc受体位点和分解代谢位点彼此无关。